Gut Microbial-Derived Metabolites as Immune Modulators of T Helper 17 and Regulatory T Cells
International Journal of Molecular Sciences · 16.01.2023 · 24 (2) · 1806
DOI: 10.3390/ijms24021806 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.01.2023. Verfasst von Laura Calvo-Barreiro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, NY 10065, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Microbiota. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The gut microbiota and its derived metabolites greatly impact the host immune system, both innate and adaptive responses. Gut dysbiosis and altered levels of microbiota-derived metabolites have been described in several immune-related and immune-mediated diseases such as intestinal bowel disease, multiple sclerosis, or colorectal cancer. Gut microbial-derived metabolites are synthesized from dietary compounds ingested by the host or host-produced metabolites, and additionally, some bacterial products can be synthesized de novo. In this review, we focus on the two first metabolites families including short-chain fatty acids, indole metabolites, polyamines, choline-derived compounds, and secondary bile acids. They all have been described as immunoregulatory molecules that specifically affect the adaptive immune system and T helper 17 and regulatory T cells. We discuss the mechanisms of action and the consequences in health and diseases related to these gut microbial-derived metabolites. Finally, we propose that the exogenous administration of these molecules or other compounds that bind to their immunoregulatory receptors in a homologous manner could be considered therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, NY 10065, USA.
- Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
ORCID-Profile: Laura Calvo-Barreiro, Moustafa Gabr
Zitieren
APA
Calvo-Barreiro, L., Zhang, L., Abdel-Rahman, S. A., Naik, S. P., & Gabr, M. (2023). Gut Microbial-Derived Metabolites as Immune Modulators of T Helper 17 and Regulatory T Cells. International Journal of Molecular Sciences, 24(2), 1806. https://doi.org/10.3390/ijms24021806
Vancouver
Calvo-Barreiro L, Zhang L, Abdel-Rahman SA, Naik SP, Gabr M. Gut Microbial-Derived Metabolites as Immune Modulators of T Helper 17 and Regulatory T Cells. International Journal of Molecular Sciences. 2023;24(2):1806. doi:10.3390/ijms24021806
BibTeX
@article{CalvoBarreiro2023,
author = {Calvo-Barreiro, Laura and Zhang, Longfei and Abdel-Rahman, Somaya A and Naik, Shivani Paritosh and Gabr, Moustafa},
title = {Gut Microbial-Derived Metabolites as Immune Modulators of T Helper 17 and Regulatory T Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {2},
pages = {1806},
doi = {10.3390/ijms24021806}
}
EUVIMED